Patents Assigned to Phoenix Pharmaceuticals, Inc.
  • Diagnostic Kit
    Publication number: 20210061893
    Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.
    Type: Application
    Filed: November 4, 2020
    Publication date: March 4, 2021
    Applicant: Phoenix Pharmaceuticals, Inc.
    Inventors: Jaw-Kang Chang, Rong-Ming Lyu
  • Phoenixin peptides
    Patent number: 10836812
    Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.
    Type: Grant
    Filed: January 2, 2017
    Date of Patent: November 17, 2020
    Assignee: Phoenix Pharmaceuticals, Inc.
    Inventors: Jaw-Kang Chang, Rong-Ming Lyu
  • Phoenixin Peptides
    Publication number: 20170145083
    Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.
    Type: Application
    Filed: January 2, 2017
    Publication date: May 25, 2017
    Applicant: Phoenix Pharmaceuticals, Inc.
    Inventors: Jaw-Kang Chang, Rong-Ming Lyu
  • Phoenixin peptides
    Patent number: 9534045
    Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: January 3, 2017
    Assignee: Phoenix Pharmaceuticals, Inc.
    Inventors: Jaw-Kang Chang, Rong-Ming Lyu
  • Phoenixin Peptides
    Publication number: 20150322141
    Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.
    Type: Application
    Filed: April 27, 2015
    Publication date: November 12, 2015
    Applicant: Phoenix Pharmaceuticals, Inc.
    Inventors: Jaw-Kang Chang, Rong-Ming Lyu
  • Phoenixin peptides
    Patent number: 9018350
    Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.
    Type: Grant
    Filed: May 25, 2012
    Date of Patent: April 28, 2015
    Assignee: Phoenix Pharmaceuticals, Inc.
    Inventors: Jaw-Kang Chang, Rong-Ming Lyu
  • Phoenixin Peptides
    Publication number: 20140163202
    Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.
    Type: Application
    Filed: May 25, 2012
    Publication date: June 12, 2014
    Applicant: Phoenix Pharmaceuticals, Inc.
    Inventors: Jaw-Kang Chang, Rong-Ming Lyu
  • Cell permeable bioactive peptide conjugates
    Patent number: 7928186
    Abstract: Cell permeable bioactive peptide conjugates having a first bioactive peptide region coupled to a second transport peptide region allowing transfer of the first bioactive peptide region and the second transport peptide region across biological membranes to enter intact living cells for regulation of biological responses.
    Type: Grant
    Filed: August 2, 2007
    Date of Patent: April 19, 2011
    Assignee: Phoenix Pharmaceuticals, Inc.
    Inventor: Jaw-Kang Chang
  • Cell growth regulation system
    Patent number: 6835806
    Abstract: Stable water soluble polypeptides which are potent inhibitors of endothelial cell proliferation and of angiogenesis. Polypeptide inhibitors of endothelial cell growth may have important uses in the elucidation of the mechanism of angiogenesis, disease diagnosis and prognostication, and drug therapies for use in animals and humans.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: December 28, 2004
    Assignee: Phoenix Pharmaceuticals, Inc.
    Inventor: Jaw-Kang Chang
  • Cell growth regulation system
    Publication number: 20020058620
    Abstract: Stable water soluble polypeptides which are potent inhibitors of endothelial cell proliferation and of angiogenesis. Polypeptide inhibitors of endothelial cell growth may have important uses in the elucidation of the mechanism of angiogenesis, disease diagnosis and prognostication, and drug therapies for use in animals and humans.
    Type: Application
    Filed: March 30, 2001
    Publication date: May 16, 2002
    Applicant: Phoenix Pharmaceuticals, Inc.
    Inventor: Jaw-Kang Chang